Tagraxofusp after Transplant: A Phase I Safety Study of Post-HCT Maintenance in CD123+ Myeloid Malignancies

Authors

• M Kasner

Publication/Presentation Date

2-2026

Volume

32

Issue

2

First Page

398

Last Page

399

Published In/Presented At

https://doi.org/10.1016/j.jtct.2025.12.570

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article